SCCG signs distribution agreement with Wynta for its affiliate marketing software in North America

Industry

Gaming and sports betting consultancy SCCG Management announced Tuesday a partnership with the Singapore-based software company, Wynta, to distribute their tracking and attribution software within the North American gaming markets.

The award-winning Wynta platform is a SaaS affiliate marketing software in the iGaming space, catering to online businesses across markets and verticals.

Stephen Crystal, Founder, and CEO of SCCG Management, said: “We are pleased to be partnering with this ‘best in class’ solution for Tracking and Attribution. The team at Wynta, equipped with over 30 years of collective expertise in associated industries, created an innovative platform to present advanced technology and ground-breaking features for established and emerging clientele.”

Vanessa Braganza, Chief Operating Officer of Wynta, commented: “Wynta shares a great relationship with SCCG and we are ecstatic that our partnership commences at just the right time for us in the iGaming SaaS Martech space. We are currently poised to scale and enter new markets, so what better way than to make a mark with the expertise that SCCG’s Dream Team brings to the table!”

With the collaboration of SCCG Management and Wynta, focusing on distribution growth in North America, they provide “value” to the entire gaming industry. SCCG’s ability to deploy platforms and solutions across its ecosystem of gaming companies will be a “crucial driver” in the distribution of Wynta’s innovative software. Furthermore, the company announced that Wynta plans to release more feature-laden products.

Articles You May Like

Chris Moneymaker Kicks Off Triton Montenegro with Stunning High-Roller Win
Brazilian Puts On Dazzling Performance in 888poker XL Spring Series Mystery Bounty Event
Venetian Las Vegas Welcomes Mike Epps
BGC welcomes UK government’s modernization plans for casinos, urges swift implementation
2023 WSOP Winner Auctioning Bracelet to Benefit Cancer Research

Leave a Reply

Your email address will not be published. Required fields are marked *